A pool of peptides extracted from wheat bud chromatin inhibits tumor cell growth by causing defective DNA synthesis

Cell Division

Francesco Grignani³  Lanfranco Barberini²  Cristiano Marinelli³  Matteo Marchesini³  Francesco Mancini²  Paula M De Angelis¹  Teresa Secca²  Loretta Mancinelli² 

[1] Clinic for Diagnostics and Intervention, Oslo University Hospital-Rikshospitalet, Oslo, Norway;Department of Cellular and Environmental Biology, University of Perugia via Pascoli, 06123, Perugia, Italy;Department of Clinical and Experimental Medicine, University of Perugia, Faculty of Medicin, S.Andrea delle Fratte, 06132, Perugia, Italy

关键词: BrdUrd comet;    G2 checkpoint;    H2AX;    Chromatin peptides;    DNA damage;   

Others  :  790477
DOI  :  10.1186/1747-1028-8-11

 received in 2013-06-04, accepted in 2013-08-02,  发布年份 2013

【 摘 要 】

Background

We previously reported that a pool of low molecular weight peptides can be extracted by alkali treatment of DNA preparations obtained from prokaryotic and eukaryotic cells after intensive deproteinization. This class of peptides, isolated from wheat bud chromatin, induces growth inhibition, DNA damage, G2 checkpoint activation and apoptosis in HeLa cells. In this work we studied their mechanism of action by investigating their ability to interfere with DNA synthesis.

Methods

BrdUrd comet assays were used to detect DNA replication defects during S phase. DNA synthesis, cell proliferation, cell cycle progression and DNA damage response pathway activation were assessed using 3H-thymidine incorporation, DNA flow cytometry and Western blotting, respectively.

Results

BrdUrd labelling close to DNA strand discontinuities (comet tails) detects the number of active replicons. This number was significantly higher in treated cells (compared to controls) from entry until mid S phase, but markedly lower in late S phase, indicating the occurrence of defective DNA synthesis. In mid S phase the treated cells showed less 3H-thymidine incorporation with respect to the controls, which supports an early arrest of DNA synthesis. DNA damage response activation was also shown in both p53-defective HeLa cells and p53-proficient U2OS cells by the detection of the phosphorylated form of H2AX after peptide treatment. These events were accompanied in both cell lines by an increase in p21 levels and, in U2OS cells, of phospho-p53 (Ser15) levels. At 24 h of recovery after peptide treatment the cell cycle phase distribution was similar to that seen in controls and CDK1 kinase accumulation was not detected.

Conclusion

The data reported here show that the antiproliferative effect exhibited by these chromatin peptides results from their ability to induce genomic stress during DNA synthesis. This effect seems to be S-phase specific since surviving cells are able to progress through their normal cell cycle when the peptide fraction is removed from the culture medium. It is likely that the subsequent apoptosis is a consequence of the failed attempt of the tumour cells to repair the DNA damage induced by the peptides.

【 授权许可】

   
2013 Mancinelli et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Gianfranceschi GL, Amici D, Guglielmi L: Restrinction of template capacity of rat liver chromatin by a non-histone peptide from calf thymus. Nature 1976, 262:622-623.
• [2]Mancinelli L, Castigli E, Qualadrucci P, Gianfranceschi GL, Bramucci M, Miano A, Amici D: Small acidic peptides from wheat germ chromatin I. Physiol Chem Phys Med NMR 1992, 24:97-107.
• [3]Amici D, Rossi GB, Cioè L, Matarese GP, Dolei A, Gianfranceschi GL: Low-molecular- weight peptide inhibits RNA synthesis in human leukemic and phytohemagglutinin-stimulated leukocites and globin mRNA transcription in differentiating Friends cells. Proc Natl Acad Sci USA 1977, 74:3869-3873.
• [4]Mancinelli L, Chillemi F, Cardellini E, Marsili V, Giavarini F, De Angelis L, Lugaro G, Gianfranceschi GL: Molecular models of acidic peptides from pea bud chromatin and seminal plasma: divalent cations-mediated interaction with DNA. Biol Chem 1999, 380:31-40.
• [5]Gianfranceschi GL, Amici D, Guglielmi L: Amplification of template capacity of mammalian DNA following extraction of low molecular weight peptides. Physiol Chem Phys 1979, 11:507-515.
• [6]Gianfranceschi GL, Hillar M, Chan JT, Amici D: Low molecular weight peptidic fraction in the chromatin from normal and cancer cells control of transcription. Molec Biol Rep 1980, 6:95-103.
• [7]Mancinelli L, De Angelis PM, Annulli L, Padovini V, Elgjo K, Gianfranceschi GL: A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells. Mol Cancer 2009, 8:55-66.
• [8]Podhorecka M, Skladanowski A, Bozo P: H2AX phosphorylation: its role in DNA damage response and cancer therapy. J Nucleic Acids 2010, 2011:920161-920170.
• [9]Southern SA, Herrington CS: Disruption of cell cycle central by human papillomaviruses with special reference to cervical carcinoma. Intern J Gynecol Cancer 2000, 2000(4):263-274.
• [10]Zache N, Lambert JMR, Rokaeus N, Shen J, Hainaul P, Bergman J, Wiman KG, Bykov VJN: Mutant p53 targeting by the low molecular weight compound STIMA-1. Mol Oncology 2008, 2:70-80.
• [11]McGlynn A, Wasson G, O’Connor J, McKelvey-Martin V, Downes S: The Bromodeoxyuridine comet assay: detection of maturation of recently replicated DNA in individual cells. Cancer Res 1999, 59:5912-5916.
• [12]Goldar A, Labit H, Marheineeke K, Hyrien O: A dynamic stochastic model for DNA replication initiation in early embryos. PLoS ONE 2008, 3(Suppl 8):e2919.
• [13]Goldar A, Marsolier-Kergoat MC, Hyrien O: Universal temporal profile of replication origin activation in eukaryotes. PLoS ONE 2009, 4(Suppl 6):e5899.
• [14]Rashi-Elkeles S, Elkon R, Shavit S, Lerenthal Y, Linhart C, Kupershtein A, Amariglio N, Rechavi G, Shamir R, Shiloh Y: Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol Oncology 2011, XXX:1-13.
• [15]Appella E, Anderson CW: Post-translation modification and activation of p53 by genotoxic stresses. Eur J Biochem 2001, 268:2764-2772.
• [16]Origanti S, Cai SR, Munir AZ, White LS, Piwinca-Worms H: Synthetic lethality of Chk1 inhibition combined with p53 and 7or p21 loss during a DNA damage response in normal and tumor cells. Oncogene 2012, 19:19.
• [17]Bhutia SK, Maiti KT: Targeting tumors with peptides from natural sources. Trends Biotechnol 2008, 26:210-217.
• [18]Gianfranceschi GL, Czerwinski A, Angellillo A, Marsili V, Castigli E, Mancinelli L, Miano A, Bramucci M, Amici D: Molecular models of small phosphorylated chromatin peptides. Structure-function relationship and regulatory activity on in vitro transcription and on cell growth and differentiation. Peptides 1994, 15:7-13.
• [19]Kozaki Y, Kubo M, Ariki T, Onishi T, Zhu D, Muramatu M: Properties of three proteinases functioning at G1, S and G2 phases in HeLa cells and their inhibition by guanidino-and amidino-acid esters. Biol Pharm Bull 1994, 17:185-191.